Yuanshu Pharmaceutical Technology Co., Ltd.
Yuanshu Pharmaceutical Technology Co., Ltd. was established in 2015 and is headquartered in Nanjing. It is a national-level high-tech enterprise that focuses on electronic materials while also engaging in the development of highly complex pharmaceutical intermediates. The company has obtained ISO 9001 certification for its international quality management system, been recognized as a private science and technology enterprise in Jiangsu Province, and awarded the “Jiangsu Good Technology” title. In 2020, it was listed on the Science and Technology Innovation Board of the Jiangsu Provincial Equity Exchange Center.
At its state-of-the-art R&D center located in the Jiangsu Life Science Innovation Park in Nanjing, the company has established a highly efficient technology platform dedicated to the electronic chemicals sector. The company focuses on developing a portfolio of specialty modified epoxy resins, curing agents, accelerators, specialized functional materials, electroplating additives, and flame retardants, which are widely used in industrial applications such as semiconductor packaging, high-frequency and high-speed copper-clad laminates (CCL), high-performance composite materials, electronic packaging, and flame-retardant systems.
In the field of electronic materials, the company continues to pursue structural design, optimize synthetic routes, and evaluate application performance, focusing on addressing key technical challenges related to the purity, stability, compatibility, and environmental sustainability of high-end electronic chemicals. At the same time, the company maintains and concurrently advances CRO/CDMO services for clinically challenging drug intermediates, as well as ADC drug development, thereby establishing a dual‑technology support system spanning electronic materials and pharmaceutical chemistry.
The company’s R&D team possesses expertise in process development and intellectual property management, and rigorously enforces confidentiality and IP protection protocols for customer‑specific projects. To date, the company has been granted 21 invention patents, with 5 patent applications currently under examination and 11 additional invention patent applications pending. Upholding the principle that “technological innovation is the driving force behind corporate growth,” the company is committed to becoming a trusted, specialized supplier and technology partner in the fields of electronic materials and fine chemicals.
Date of establishment
Industry experience
Product quantity
Company patent
Research and Development Innovation
Development History
Corporate culture
Corporate Mission
Producing high-quality products and delivering trustworthy service!
Corporate Spirit
Technological innovation is the driving force behind corporate development!
Win-win
Equipped with state-of-the-art instruments and a robust quality management system, we are committed to excellence and deliver products that meet and exceed our customers’ expectations.